- Joined
- Jul 15, 2007
- Messages
- 49
- Reaction score
- 0
i'm confused.... say a drug has low bioavailability (i.e. propranolol with F= 10%). if someone has liver disease where there is a decreased first-pass effect, does that mean an increase in bioavailability and increase effect in the drug?